For patients diagnosed with glioma, a deadly form of brain tumor, the future can be very uncertain. While gliomas are often fatal within two years of diagnosis, some patients can survive for 10 years or more. Predicting the course of a patient's disease at diagnosis is critical in selecting the right therapy and in helping patients and their families to plan their lives.

Cuff devices for blood pressure measurement are inconvenient, and mobile device apps for blood pressure measurement that are now being introduced may lack accuracy. To solve this problem, a team of Michigan State University scientists has created a new app and hardware for smartphones to measure blood pressure with accuracy that may rival arm-cuff devices.

A new smartphone app may help reduce the number of hospital readmissions in patients who have been treated for a heart attack, according to a study presented at the American College of Cardiology's Cardiovascular Summit in Las Vegas. The "Corrie" app, developed for iPhone, is the first cardiology app for the Apple CareKit platform. The app is designed to help patients navigate the hospital discharge process by educating them about heart disease.

80% of the most popular health applications available on Android do not comply with standards intended to prevent the misuse and dissemination of their users' data. This is the finding of a European study started in 2016 and involving Agustí Solanas, head of the Smart Health research group at the URV's Department of Computer Engineering and Mathematics, and researchers from the University of Piraeus (Greece) headed by Constantinos Patsakis.

Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations to understand resistance to osimertinib - an anticancer drug used to treat types of lung cancer. Osimertinib binds tightly to a protein, epidermal growth factor receptor (EGFR), which is overexpressed in many tumours. EGFR is involved in a pathway that signals for cell proliferation, and so is a target for drugs. Blocking the action of EGFR (inhibiting it) can switch it off, and so is a good way to treat the disease.

In a major advancement in nanomedicine, Arizona State University (ASU) scientists, in collaboration with researchers from the National Center for Nanoscience and Technology (NCNST), of the Chinese Academy of Sciences, have successfully programmed nanorobots to shrink tumors by cutting off their blood supply.

When it comes to biometric sensors, human skin isn't an ally. It's an obstacle. The University of Cincinnati is developing cutting-edge methods to overcome this barrier without compromising the skin and its ability to prevent infection and dehydration. By making better noninvasive tests, researchers can open up enormous opportunities in medicine and the fitness industry.